Pages that link to "Q44617739"
Jump to navigation
Jump to search
The following pages link to Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients (Q44617739):
Displaying 50 items.
- Primary biliary cirrhosis (Q21202919) (← links)
- (Q24186229) (← links)
- Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health Perspective (Q26781780) (← links)
- Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists (Q26796355) (← links)
- Primary biliary cirrhosis: From bench to bedside (Q26799419) (← links)
- Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy (Q26853649) (← links)
- Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study (Q33419647) (← links)
- Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study (Q33641759) (← links)
- Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid (Q33920325) (← links)
- Biliary physiology and disease: reflections of a physician-scientist (Q34108895) (← links)
- Current status of therapy in autoimmune liver disease (Q34408950) (← links)
- Functional and structural features of cholangiocytes in health and disease (Q35933236) (← links)
- Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis (Q36914749) (← links)
- Overlap syndromes with autoimmune hepatitis in chronic cholestatic liver diseases (Q37346015) (← links)
- Natural history and management of primary biliary cirrhosis (Q37355843) (← links)
- Biochemical response to ursodeoxycholic acid predicts long‐term outcome in Japanese patients with primary biliary cirrhosis (Q37855976) (← links)
- Treatment of Primary Biliary Cirrhosis with Ursodeoxycholic Acid, Budesonide and Fibrates (Q37892291) (← links)
- Current pharmacotherapy for cholestatic liver disease (Q38055205) (← links)
- Primary biliary cirrhosis and bile acids (Q38058979) (← links)
- Long-term survival after perforated diverticulitis (Q38448011) (← links)
- Underestimated Male Prevalence of Primary Biliary Cholangitis in China: Results of a 16-yr cohort study involving 769 patients (Q38659201) (← links)
- Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis. (Q38699595) (← links)
- Geoepidemiology and changing mortality in primary biliary cholangitis (Q39213467) (← links)
- Old and new treatments for primary biliary cholangitis (Q39216355) (← links)
- Diagnostic accuracy of two tests for determination of anti-m2 in the diagnosis of primary biliary cirrhosis: Is it possible to predict the course of the disease? (Q39542696) (← links)
- The Natural History and Prognosis of Primary Biliary Cirrhosis with Clinical Features of Autoimmune Hepatitis (Q41303819) (← links)
- New developments in the treatment of primary biliary cholangitis - role of obeticholic acid (Q41531249) (← links)
- Recent developments in the management of idiopathic cholestatic liver disease (Q42406650) (← links)
- Is there a role for tetrathiomolybdate in the treatment of primary biliary cirrhosis? (Q43155895) (← links)
- Early biochemical response to ursodeoxycholic acid predicts symptom development in patients with asymptomatic primary biliary cirrhosis (Q46049458) (← links)
- Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis (Q46408092) (← links)
- Natural history of primary biliary cirrhosis (Q46608065) (← links)
- The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study (Q46614923) (← links)
- Mortality attributable to cholestatic liver disease in the United States. (Q46719878) (← links)
- Geotherapeutics of primary biliary cirrhosis: bright and sunny around the Mediterranean but still cloudy and foggy in the United Kingdom (Q46982754) (← links)
- Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history. (Q47567609) (← links)
- Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome (Q47787189) (← links)
- A brief review on prognostic models of primary biliary cholangitis (Q48342063) (← links)
- Ursodeoxycholic acid suppresses eosinophilic airway inflammation by inhibiting the function of dendritic cells through the nuclear farnesoid X receptor (Q49153341) (← links)
- Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients with Primary Biliary Cholangitis (Q50049891) (← links)
- Prevalence and incidence of primary biliary cirrhosis are increasing in Finland (Q51108387) (← links)
- Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study (Q51137626) (← links)
- A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemia. (Q53591523) (← links)
- Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study. (Q55044287) (← links)
- Guidelines for the management of primary biliary cirrhosis (Q56429943) (← links)
- Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: Results of a 14-year cohort study (Q57603219) (← links)
- Chronische cholestatische Leberkrankheiten (Q59528257) (← links)
- Efficacy of ursodeoxycholic acid combined with Tongdan Decoction () on immunological indices and histopathological changes in primary biliary cirrhosis patients (Q83200621) (← links)
- Primary biliary cirrhosis (Q84230884) (← links)
- Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome (Q84441124) (← links)